Phillips Named Director of Blood and Marrow Transplant and Leukemia Program

September 03, 2002

Gordon L. Phillips II, M.D., was recently named director of the Blood and Marrow Transplant and Leukemia Program at the James P. Wilmot Cancer Center at the University of Rochester Medical Center.

Phillips is an expert in stem cell transplantation, leukemia therapy, and transplant biology and he will oversee this combined program, which provides more than 120 transplants each year.

“Dr. Phillips is a national leader in the treatment of hematologic cancers,” said Richard I. Fisher, M.D., director, James P. Wilmot Cancer Center and director of cancer services, Strong Health. “He is an outstanding clinician and scientist and his arrival, in combination with our other highly skilled clinicians, establishes the Wilmot Cancer Center as one of the top East Coast center for the treatment of non-Hodgkin’s lymphoma, Hodgkin’s disease, chronic lymphocytic leukemia, multiple myeloma and associated disorders.”

Phillips was previously director of blood and marrow transplant program at the University of Maryland’s Greenebaum Cancer Center and before that, the University of Kentucky. He also served as director of the leukemia and bone marrow transplant program of British Columbia.

His research interests include various aspects of stem cell transplantation, including nonmyeloablative (mini-dose) transplants and ‘alternative donors’ for allogeneic transplants. He has developed several innovative clinical trials related to stem cell transplantation and is particularly interested in lymphoma, leukemia, and multiple myeloma.

He is a graduate of University of Oklahoma School of Medicine, completed his residency at the University of North Carolina at Chapel Hill, and served as a clinical and research fellow in hematology/oncology at Washington University School of Medicine.

Phillips is a member of numerous professional societies, including the American Association of Cancer Research, American Society of Clinical Oncology, American Society of Hematology, international Society of Experimental Hematology, and the Autologous and International Bone Marrow Transplant Registries.

Phillips is a member of the Editorial Boards for Bone Marrow Transplantation, Cancer Research, and Biology of Blood and Marrow Transplantation. Phillips has also authored more than 200 book chapters, peer-reviewed journal articles, and abstracts in the field.

For Media Inquiries:
Leslie White
(585) 273-1119
Email Leslie White